Unity Biotechnology, Inc. (UBX) Financials

UBX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 69.3 million 33.1 million
2023-06-30 101.0 million 51.6 million
2023-03-31 114.3 million 55.6 million
2022-12-31 124.4 million 57.5 million

UBX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -7.1 million 2.1 million
2023-06-30 -11.1 million 2.4 million
2023-03-31 -11.3 million 2.3 million
2022-12-31 -10.4 million 2.3 million

UBX Net Income

No data available :(

UBX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 45.9 million - 24.4 million
2023-06-30 69.1 million 4.1 million 25.3 million
2023-03-31 83.4 million 7.6 million 26.2 million
2022-12-31 94.8 million 10.9 million 30.1 million

UBX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 14.6 million
2023-06-30 14.4 million
2023-03-31 14.3 million
2022-12-31 14.1 million

UBX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 11000 4.9 million 4.4 million -
2023-06-30 - 6.5 million 5.4 million -
2023-03-31 - 5.8 million 4.8 million -
2022-12-31 37000 8.6 million 5.3 million -

UBX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 308000
2023-06-30 - 314000
2023-03-31 - 329000
2022-12-31 -236000 409000

UBX

Price: $1.63

52 week price:
1.47
3.82

Earnings Per Share: -3.20 USD

P/E Ratio: -0.53

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 71934

Market Capitalization: 25.5 million

Links: